The First AI-Designed Protein Has Entered Human Clinical Trials

A cancer-targeting protein designed entirely by AI has cleared safety hurdles and is now being tested in patients—a milestone for computational biology.

---

Related Reading

- Scientists Used AI to Discover a New Antibiotic That Kills Drug-Resistant Bacteria - Your Doctor Has an AI Now: Medicine's Quiet Revolution - Researchers Taught an AI to Smell — And It's Already Detecting Cancer - This AI Can Generate Functional Proteins That Don't Exist in Nature - AI-Designed Cancer Drug Shows 78% Tumor Reduction in Phase 2 Trials